This month’s roundup features stories on traceable bacteria, significantly increased drug prices, colorful potatoes for cancer prevention, breast cancer drugs affecting fertility, DNA editing in human embryos, and a series of posts on Risperdal.
Have a perspective on one of these stories? Submit your post to the AAPS Blog!
- “Study Finds People Can Be Identified by the Bacteria They Breathe Out,” by Josh L. Davis, IFL Science, September 22, 2015
- “Why Would Martin Shkreli Hike an Old Drug Price by 5000%? Only a ‘Moron’ Would Ask,” by John Carroll, Fierce Biotech, September 20, 2015
- “British Scientists Seek Permission to Edit DNA in Human Embryos,” by Rob Stein, Shots, NPR, September 18, 2015
- “Clinical Trial Shows Vaccine Removes Precancerous Cervical Lesions,” by Karla Tecson, International Business Times, September 18, 2015
- “New Drugs Could Stop the Growth of Drug-resistant Childhood Tumours,” eLife, September 14, 2015
- “Wikipedia Editors Woo Scientists to Improve Content Quality,” by Richard Hodson and Nature magazine, Scientific American, September 8, 2015
- “Drugs that Live Long Will Prosper,” The Economist, September 5, 2015
- “Colorful Potatoes May Pack Powerful Cancer Prevention Punch,” by Matt Swayne, Penn State News, August 26, 2015
- “Breast Cancer Patients Worry About Effects of Tamoxifen on Fertility,” by Suzanne Elvidge, The Pharmaceutical Journal, August 25, 2015
- “America’s Most Admired Lawbreaker,” by Steven Brill, The Huffington Post